NDC00555-9016-58: NORGESTIMATE AND ETHINYL ESTRADI.
NORGESTIMATE AND ETHINYL ESTRADI. Key specifications include administration: ORAL, primary_container_type: CARD, primary_container_content_quantity: 28.0 TABLETS, active_medicament_medicinal_strength: 0.25 MILLIGRAMS NORGESTIMATE ACTIVE INGREDIENT AND 0.35 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS, ORTHO-CYCLEN. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-662-6868, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | CARD |
| primary_container_content_quantity | 28.0 TABLETS |
| active_medicament_medicinal_strength | 0.25 MILLIGRAMS NORGESTIMATE ACTIVE INGREDIENT AND 0.35 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS, ORTHO-CYCLEN |
| NSN | 6505-01-662-6868 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 28.0 TABLETS |
| PRIMARY CONTAINER TYPE | CARD |
| SPECIAL FEATURES | NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS; ORTHO-CYCLEN: 21 BLUE TABLETS CONTAIN 0.25MG NORGESTIMATE AND 0.35MG ETHINYL ESTRADIOL; 7 DARK GREEN TABLETS CONTAIN INERT INGREDIENTS; 28 TABLETS PER CYCLE, 6 CYCLES PER PACKAGE, TOTAL 168 TABLETS; STORE AT 25 C (77 F); EXCURSIONS PERMITTED TO 15-30 C (59 - 86 F). KEEP OUT OF THE REACH OF CHILDREN. PROTECT FROM LIGHT. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS, ORTHO-CYCLEN |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.25 MILLIGRAMS NORGESTIMATE ACTIVE INGREDIENT AND 0.35 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT |